Ethacrynic acid - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for ethacrynic acid and what is the scope of patent protection?
Ethacrynic acid
is the generic ingredient in two branded drugs marketed by Bausch, Adaptis, Agnitio, Alvogen, Amneal Pharms Co, Chartwell Rx, Endo Operations, Hikma, Lupin Ltd, Sciegen Pharms Inc, and Upsher Smith Labs, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.There are thirteen drug master file entries for ethacrynic acid. Ten suppliers are listed for this compound.
Summary for ethacrynic acid
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 11 |
| NDAs: | 11 |
| Drug Master File Entries: | 13 |
| Finished Product Suppliers / Packagers: | 10 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Clinical Trials: | 4 |
| Patent Applications: | 6,655 |
| Drug Prices: | Drug price trends for ethacrynic acid |
| What excipients (inactive ingredients) are in ethacrynic acid? | ethacrynic acid excipients list |
| DailyMed Link: | ethacrynic acid at DailyMed |
Recent Clinical Trials for ethacrynic acid
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Pari Pharma GmbH | Phase 1 |
| Neupharma Srl | Phase 1 |
| Centro Ricerche Cliniche di Verona | Phase 1 |
Pharmacology for ethacrynic acid
| Drug Class | Loop Diuretic |
| Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for ethacrynic acid
US Patents and Regulatory Information for ethacrynic acid
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sciegen Pharms Inc | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 211232-001 | Aug 27, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Agnitio | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 211809-001 | Jul 12, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 207262-001 | Feb 23, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Amneal Pharms Co | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 208805-001 | May 8, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
